Article
Prognostic impact of nectin-like molecule-5 (CD155) expression in non-small cell lung cancer.
Journal of translational medicine - 12 Sept 2024
Popa-Navarro Xitlally, Avilés-Salas Alejandro, Hernández-Pedro Norma, Orozco-Morales Mario, Caballé-Pérez Enrique, Castillo-Ruiz Cesar, Lucio-Lozada José, Barrios-Bernal Pedro, Hernandez-Martinez Juan-Manuel, Arrieta Oscar
Abstract excerpt
BACKGROUND: CD155 is a transmembrane protein that inhibits antitumor immune response and represents a predictor of worse prognosis in non-small-cell lung cancer (NSCLC). However, it remains unexplored its association with clinical characteristics and genomic status of Latin American patients. This study characterizes the CD155 expression and its clinical implications in this population. METHODS: Tissue biopsies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
